This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Sebastian Kaerger
Introduction
Sebastian Kaerger is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation therapies. His work focuses on improving the stability and efficacy of medications.
Latest Patents
Sebastian Kaerger holds 1 patent for his invention titled "Compositions of glycopyrronium salt for inhalation." This patent describes a process for preparing dry powder formulations of a glycopyrronium salt that exhibit good stability. The innovative process involves micronising a glycopyrronium salt with an anti-adherent agent and subsequently admixing carrier particles to create the final dry powder formulation.
Career Highlights
Kaerger is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge research and development projects that aim to enhance patient care through innovative drug delivery systems.
Collaborations
Throughout his career, Sebastian has collaborated with esteemed colleagues, including Barbara Haeberlin and Frank Stowasser. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical products.
Conclusion
Sebastian Kaerger's contributions to inhalation therapies highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the pharmaceutical industry positively.